 Paul MacLean
Concepts (647)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 56 | 2025 | 3027 | 5.030 |
Why?
| | Weight Gain | 26 | 2023 | 542 | 4.500 |
Why?
| | Energy Metabolism | 33 | 2025 | 935 | 4.390 |
Why?
| | Weight Loss | 26 | 2025 | 803 | 4.080 |
Why?
| | Physical Conditioning, Animal | 10 | 2025 | 246 | 2.380 |
Why?
| | Rats, Wistar | 19 | 2024 | 453 | 2.210 |
Why?
| | Energy Intake | 18 | 2025 | 513 | 2.120 |
Why?
| | Dietary Fats | 14 | 2019 | 303 | 1.810 |
Why?
| | Caloric Restriction | 9 | 2025 | 125 | 1.750 |
Why?
| | Ovariectomy | 11 | 2025 | 158 | 1.720 |
Why?
| | Body Weight | 16 | 2024 | 997 | 1.480 |
Why?
| | Lactation | 8 | 2020 | 191 | 1.450 |
Why?
| | Adipose Tissue | 15 | 2022 | 649 | 1.400 |
Why?
| | Appetite | 3 | 2025 | 71 | 1.350 |
Why?
| | Diet, High-Fat | 15 | 2023 | 257 | 1.330 |
Why?
| | Milk, Human | 6 | 2022 | 171 | 1.260 |
Why?
| | Body Composition | 12 | 2024 | 706 | 1.210 |
Why?
| | Ovary | 5 | 2024 | 226 | 1.160 |
Why?
| | Rats | 34 | 2024 | 5585 | 1.140 |
Why?
| | Adipocytes | 7 | 2025 | 222 | 1.110 |
Why?
| | Muscle, Skeletal | 20 | 2022 | 1772 | 1.080 |
Why?
| | Animals | 86 | 2025 | 37697 | 1.050 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 48 | 1.030 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 77 | 1.020 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 142 | 0.950 |
Why?
| | Lipid Metabolism | 9 | 2017 | 522 | 0.940 |
Why?
| | Motor Activity | 3 | 2019 | 717 | 0.940 |
Why?
| | Appetite Regulation | 2 | 2017 | 32 | 0.860 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 567 | 0.820 |
Why?
| | Biomedical Research | 3 | 2023 | 692 | 0.800 |
Why?
| | Liver | 11 | 2024 | 1848 | 0.790 |
Why?
| | Cholesterol | 5 | 2019 | 404 | 0.770 |
Why?
| | Milk | 6 | 2019 | 124 | 0.760 |
Why?
| | Fasting | 7 | 2025 | 284 | 0.760 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 247 | 0.760 |
Why?
| | Leptin | 8 | 2025 | 238 | 0.750 |
Why?
| | Vasopressins | 3 | 2021 | 60 | 0.750 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 56 | 0.750 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2023 | 316 | 0.750 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 16 | 0.740 |
Why?
| | Awards and Prizes | 1 | 2023 | 72 | 0.740 |
Why?
| | Estrogens | 3 | 2018 | 371 | 0.740 |
Why?
| | Overweight | 5 | 2025 | 594 | 0.740 |
Why?
| | Eating | 5 | 2022 | 397 | 0.730 |
Why?
| | Lipogenesis | 3 | 2019 | 64 | 0.730 |
Why?
| | Breast Feeding | 5 | 2022 | 444 | 0.720 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2021 | 67 | 0.710 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 127 | 0.710 |
Why?
| | Glycoproteins | 5 | 2005 | 356 | 0.680 |
Why?
| | Receptor, Insulin | 3 | 2015 | 94 | 0.680 |
Why?
| | Insulin | 19 | 2022 | 2492 | 0.660 |
Why?
| | Estradiol | 1 | 2024 | 524 | 0.650 |
Why?
| | Exercise | 11 | 2025 | 2133 | 0.640 |
Why?
| | Oxygen Consumption | 5 | 2019 | 714 | 0.620 |
Why?
| | Thermogenesis | 2 | 2019 | 46 | 0.620 |
Why?
| | Physical Exertion | 3 | 2011 | 209 | 0.620 |
Why?
| | Female | 67 | 2025 | 76624 | 0.620 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 213 | 0.610 |
Why?
| | Carrier Proteins | 6 | 2005 | 743 | 0.600 |
Why?
| | Cold Temperature | 2 | 2019 | 199 | 0.590 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 121 | 0.560 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 676 | 0.560 |
Why?
| | Menopause | 2 | 2019 | 317 | 0.560 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 54 | 0.560 |
Why?
| | Sex Characteristics | 3 | 2021 | 790 | 0.550 |
Why?
| | Breast Neoplasms | 6 | 2022 | 2272 | 0.540 |
Why?
| | Calorimetry, Indirect | 6 | 2025 | 86 | 0.530 |
Why?
| | Adipogenesis | 1 | 2017 | 57 | 0.530 |
Why?
| | Diet | 10 | 2023 | 1284 | 0.520 |
Why?
| | Cortical Bone | 1 | 2017 | 19 | 0.520 |
Why?
| | Insulin Resistance | 9 | 2025 | 1229 | 0.520 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 25 | 0.510 |
Why?
| | Adiposity | 5 | 2016 | 528 | 0.510 |
Why?
| | Diet, Reducing | 4 | 2021 | 90 | 0.510 |
Why?
| | Ibuprofen | 1 | 2017 | 82 | 0.500 |
Why?
| | Mice | 34 | 2025 | 18172 | 0.500 |
Why?
| | Metformin | 2 | 2018 | 331 | 0.500 |
Why?
| | Placenta | 1 | 2023 | 767 | 0.490 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 97 | 0.490 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 4 | 0.480 |
Why?
| | Osteogenesis | 2 | 2017 | 199 | 0.480 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2608 | 0.470 |
Why?
| | Bone Density | 1 | 2019 | 499 | 0.470 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 412 | 0.470 |
Why?
| | Fructose | 5 | 2021 | 118 | 0.460 |
Why?
| | Oxytocin | 1 | 2015 | 51 | 0.460 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 94 | 0.440 |
Why?
| | Therapies, Investigational | 1 | 2014 | 18 | 0.440 |
Why?
| | Mothers | 4 | 2018 | 781 | 0.430 |
Why?
| | Male | 60 | 2025 | 70910 | 0.430 |
Why?
| | Feces | 7 | 2025 | 494 | 0.430 |
Why?
| | Humans | 72 | 2025 | 142526 | 0.420 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 351 | 0.420 |
Why?
| | Weight Reduction Programs | 3 | 2025 | 120 | 0.420 |
Why?
| | Fatty Acids | 8 | 2022 | 449 | 0.410 |
Why?
| | Transcription Factors | 12 | 2019 | 1728 | 0.400 |
Why?
| | Basal Metabolism | 3 | 2021 | 63 | 0.400 |
Why?
| | Fructokinases | 5 | 2021 | 35 | 0.400 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2002 | 54 | 0.390 |
Why?
| | Disease Models, Animal | 11 | 2021 | 4483 | 0.390 |
Why?
| | Overnutrition | 1 | 2012 | 30 | 0.380 |
Why?
| | Fatty Liver | 5 | 2018 | 244 | 0.380 |
Why?
| | Pregnancy | 10 | 2023 | 7113 | 0.370 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 78 | 0.360 |
Why?
| | Blood Glucose | 10 | 2019 | 2304 | 0.360 |
Why?
| | Feeding Behavior | 5 | 2025 | 686 | 0.360 |
Why?
| | Recurrence | 4 | 2019 | 1111 | 0.350 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 1083 | 0.350 |
Why?
| | Sheep | 4 | 2023 | 878 | 0.340 |
Why?
| | Estrous Cycle | 1 | 2010 | 22 | 0.330 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 341 | 0.330 |
Why?
| | Lipoproteins | 3 | 2000 | 163 | 0.320 |
Why?
| | Body Mass Index | 11 | 2025 | 2406 | 0.320 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 32 | 0.320 |
Why?
| | Homeostasis | 7 | 2015 | 637 | 0.320 |
Why?
| | RNA, Messenger | 10 | 2019 | 2828 | 0.320 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 146 | 0.310 |
Why?
| | Glucose | 10 | 2023 | 1038 | 0.310 |
Why?
| | Vitamin D | 1 | 2013 | 401 | 0.310 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2023 | 23 | 0.300 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2023 | 134 | 0.290 |
Why?
| | Huntington Disease | 2 | 2021 | 64 | 0.290 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 152 | 0.290 |
Why?
| | Cattle | 6 | 2025 | 988 | 0.290 |
Why?
| | Time Factors | 11 | 2019 | 7006 | 0.290 |
Why?
| | Behavior Therapy | 2 | 2021 | 283 | 0.280 |
Why?
| | Gastrointestinal Microbiome | 3 | 2023 | 727 | 0.280 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 33 | 0.270 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1254 | 0.260 |
Why?
| | Adult | 32 | 2025 | 39715 | 0.260 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5967 | 0.260 |
Why?
| | Triglycerides | 8 | 2019 | 512 | 0.250 |
Why?
| | Adiponectin | 5 | 2025 | 243 | 0.250 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 67 | 0.250 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 580 | 0.250 |
Why?
| | Neurons | 1 | 2015 | 1626 | 0.250 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2167 | 0.250 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 283 | 0.240 |
Why?
| | Mice, Knockout | 12 | 2021 | 3081 | 0.240 |
Why?
| | Birds | 2 | 2025 | 92 | 0.240 |
Why?
| | Dehydration | 2 | 2016 | 54 | 0.240 |
Why?
| | Campylobacter jejuni | 1 | 2025 | 16 | 0.240 |
Why?
| | Lymphoma | 1 | 2007 | 228 | 0.240 |
Why?
| | Campylobacter Infections | 1 | 2025 | 18 | 0.230 |
Why?
| | Cattle Diseases | 1 | 2025 | 26 | 0.230 |
Why?
| | Adenocarcinoma | 1 | 2012 | 904 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 182 | 0.230 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2561 | 0.230 |
Why?
| | Epithelium | 2 | 2019 | 313 | 0.230 |
Why?
| | Signal Transduction | 6 | 2022 | 5163 | 0.230 |
Why?
| | Muscle Proteins | 4 | 2012 | 240 | 0.230 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 353 | 0.220 |
Why?
| | Fetal Development | 3 | 2023 | 300 | 0.220 |
Why?
| | Photoperiod | 2 | 2019 | 53 | 0.220 |
Why?
| | Leukemia | 1 | 2007 | 244 | 0.220 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 409 | 0.220 |
Why?
| | Transcriptome | 3 | 2024 | 1015 | 0.220 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1500 | 0.210 |
Why?
| | Multiple Myeloma | 1 | 2007 | 285 | 0.210 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 42 | 0.210 |
Why?
| | Physical Fitness | 2 | 2016 | 207 | 0.210 |
Why?
| | Escherichia coli O157 | 1 | 2023 | 35 | 0.210 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 270 | 0.200 |
Why?
| | Animals, Newborn | 3 | 2017 | 875 | 0.200 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 20 | 0.200 |
Why?
| | Resistance Training | 3 | 2017 | 169 | 0.200 |
Why?
| | Arteriosclerosis | 1 | 2003 | 83 | 0.200 |
Why?
| | Salmonella enterica | 1 | 2023 | 57 | 0.200 |
Why?
| | Financing, Organized | 1 | 2023 | 35 | 0.200 |
Why?
| | Transcriptional Activation | 2 | 2002 | 378 | 0.200 |
Why?
| | Animal Feed | 3 | 2019 | 53 | 0.200 |
Why?
| | Sequence Analysis, RNA | 3 | 2021 | 445 | 0.190 |
Why?
| | Hospitalization | 1 | 2013 | 2293 | 0.190 |
Why?
| | Ghrelin | 3 | 2025 | 36 | 0.190 |
Why?
| | Cell Proliferation | 3 | 2017 | 2514 | 0.190 |
Why?
| | Parturition | 1 | 2023 | 67 | 0.190 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1084 | 0.190 |
Why?
| | Tamoxifen | 3 | 2021 | 203 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 153 | 0.180 |
Why?
| | Exercise Tolerance | 3 | 2016 | 283 | 0.180 |
Why?
| | Postmenopause | 4 | 2022 | 371 | 0.180 |
Why?
| | Middle Aged | 23 | 2025 | 35049 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1453 | 0.170 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 58 | 0.170 |
Why?
| | Mycoplasma ovipneumoniae | 1 | 2021 | 2 | 0.170 |
Why?
| | Malus | 1 | 2021 | 12 | 0.170 |
Why?
| | Lactoglobulins | 2 | 2018 | 6 | 0.170 |
Why?
| | Recombinases | 1 | 2021 | 7 | 0.170 |
Why?
| | Polyphenols | 1 | 2021 | 19 | 0.170 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 20 | 0.170 |
Why?
| | Mentors | 1 | 2023 | 214 | 0.170 |
Why?
| | Thinness | 3 | 2021 | 97 | 0.170 |
Why?
| | Hygromycin B | 1 | 2000 | 3 | 0.170 |
Why?
| | Liver X Receptors | 2 | 2019 | 30 | 0.170 |
Why?
| | Cinnamates | 1 | 2000 | 12 | 0.170 |
Why?
| | Disease Progression | 4 | 2018 | 2831 | 0.170 |
Why?
| | Child Development | 2 | 2018 | 504 | 0.160 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 171 | 0.160 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2021 | 56 | 0.160 |
Why?
| | Shiga-Toxigenic Escherichia coli | 1 | 2020 | 15 | 0.160 |
Why?
| | Gene Expression Profiling | 3 | 2018 | 1773 | 0.160 |
Why?
| | Hyperinsulinism | 1 | 2001 | 115 | 0.160 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.160 |
Why?
| | Fruit | 1 | 2021 | 146 | 0.160 |
Why?
| | Kynurenic Acid | 1 | 2020 | 18 | 0.160 |
Why?
| | Random Allocation | 2 | 2019 | 370 | 0.160 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1498 | 0.160 |
Why?
| | Starch | 1 | 2019 | 22 | 0.150 |
Why?
| | Nutritive Value | 1 | 2019 | 37 | 0.150 |
Why?
| | Escherichia coli Infections | 1 | 2020 | 117 | 0.150 |
Why?
| | Soil | 1 | 2021 | 209 | 0.150 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 436 | 0.150 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.150 |
Why?
| | Weaning | 1 | 2019 | 46 | 0.150 |
Why?
| | Membrane Proteins | 3 | 2015 | 1160 | 0.150 |
Why?
| | Foodborne Diseases | 1 | 2020 | 61 | 0.150 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 34 | 0.150 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2019 | 39 | 0.150 |
Why?
| | Metabolic Diseases | 2 | 2018 | 114 | 0.150 |
Why?
| | Analysis of Variance | 4 | 2016 | 1313 | 0.150 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 118 | 0.150 |
Why?
| | Ileitis | 1 | 2019 | 33 | 0.150 |
Why?
| | Anti-Infective Agents | 1 | 2021 | 243 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 2523 | 0.140 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 60 | 0.140 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 201 | 0.140 |
Why?
| | Mice, Transgenic | 7 | 2017 | 2180 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 45 | 0.140 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 46 | 0.140 |
Why?
| | Aromatase | 1 | 2018 | 31 | 0.140 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 34 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 163 | 0.140 |
Why?
| | Milk Hypersensitivity | 1 | 2018 | 20 | 0.140 |
Why?
| | Dairying | 3 | 2025 | 11 | 0.140 |
Why?
| | Glycogen | 6 | 2010 | 56 | 0.140 |
Why?
| | Perilipin-1 | 1 | 2017 | 17 | 0.140 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 31 | 0.140 |
Why?
| | Rest | 1 | 2018 | 128 | 0.140 |
Why?
| | Models, Animal | 1 | 2019 | 392 | 0.140 |
Why?
| | Postpartum Period | 2 | 2020 | 350 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 60 | 0.140 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 586 | 0.130 |
Why?
| | Malnutrition | 1 | 2019 | 85 | 0.130 |
Why?
| | Cell Size | 1 | 2017 | 90 | 0.130 |
Why?
| | Germ Layers | 1 | 2017 | 6 | 0.130 |
Why?
| | Gastrulation | 1 | 2017 | 9 | 0.130 |
Why?
| | Urea | 1 | 2017 | 83 | 0.130 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 73 | 0.130 |
Why?
| | Sucrose | 2 | 2018 | 111 | 0.130 |
Why?
| | Sphingolipids | 1 | 2018 | 82 | 0.130 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.130 |
Why?
| | Gene Editing | 1 | 2018 | 88 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2020 | 292 | 0.130 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 717 | 0.130 |
Why?
| | Running | 1 | 2019 | 229 | 0.130 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 14 | 0.130 |
Why?
| | Chromatography, Gas | 1 | 2016 | 32 | 0.130 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 63 | 0.130 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 198 | 0.130 |
Why?
| | Neural Pathways | 2 | 2011 | 305 | 0.130 |
Why?
| | Glaucoma | 1 | 2020 | 243 | 0.130 |
Why?
| | PPAR gamma | 1 | 2017 | 176 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 102 | 0.120 |
Why?
| | Dyslipidemias | 1 | 2018 | 178 | 0.120 |
Why?
| | Dogs | 1 | 2018 | 426 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 322 | 0.120 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.120 |
Why?
| | Receptors, Androgen | 1 | 2017 | 154 | 0.120 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 56 | 0.120 |
Why?
| | Paratuberculosis | 1 | 2015 | 2 | 0.120 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2015 | 3 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2017 | 178 | 0.120 |
Why?
| | Hypothalamus | 1 | 2016 | 154 | 0.120 |
Why?
| | Glucokinase | 1 | 2015 | 15 | 0.120 |
Why?
| | Obesity, Morbid | 1 | 2000 | 277 | 0.120 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 16 | 0.120 |
Why?
| | Jejunum | 1 | 2015 | 33 | 0.120 |
Why?
| | Computational Biology | 1 | 2020 | 673 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 887 | 0.120 |
Why?
| | Deer | 1 | 2015 | 34 | 0.120 |
Why?
| | Fibroblasts | 2 | 2017 | 1033 | 0.120 |
Why?
| | Down-Regulation | 3 | 2008 | 639 | 0.120 |
Why?
| | Up-Regulation | 3 | 2015 | 857 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 756 | 0.120 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 5 | 0.120 |
Why?
| | Methylnitrosourea | 2 | 2018 | 7 | 0.110 |
Why?
| | Crohn Disease | 1 | 2019 | 256 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2022 | 617 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 824 | 0.110 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 362 | 0.110 |
Why?
| | Trophoblasts | 1 | 2017 | 211 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 266 | 0.110 |
Why?
| | Allergens | 1 | 2018 | 407 | 0.110 |
Why?
| | Genetic Engineering | 1 | 2015 | 93 | 0.110 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1062 | 0.110 |
Why?
| | Caffeine | 1 | 1995 | 72 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 468 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 522 | 0.110 |
Why?
| | Research Report | 1 | 2014 | 81 | 0.110 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 270 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 37 | 0.110 |
Why?
| | Fetus | 1 | 2019 | 802 | 0.100 |
Why?
| | Infant | 5 | 2023 | 9908 | 0.100 |
Why?
| | Acinar Cells | 1 | 2013 | 13 | 0.100 |
Why?
| | Pantothenic Acid | 1 | 2013 | 5 | 0.100 |
Why?
| | United States | 3 | 2023 | 15447 | 0.100 |
Why?
| | Birth Weight | 1 | 2016 | 517 | 0.100 |
Why?
| | Mitochondria | 3 | 2022 | 973 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 70 | 0.100 |
Why?
| | Bariatric Surgery | 1 | 2017 | 227 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1727 | 0.100 |
Why?
| | Animals, Wild | 2 | 2025 | 62 | 0.100 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 26 | 0.100 |
Why?
| | Vitamin A | 1 | 2013 | 56 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2009 | 510 | 0.100 |
Why?
| | Extracellular Space | 1 | 2013 | 129 | 0.100 |
Why?
| | Genome | 1 | 2015 | 308 | 0.100 |
Why?
| | Integrases | 1 | 2013 | 123 | 0.100 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.090 |
Why?
| | DNA Methylation | 1 | 2017 | 657 | 0.090 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 654 | 0.090 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 205 | 0.090 |
Why?
| | Cell Separation | 1 | 2013 | 310 | 0.090 |
Why?
| | Alleles | 1 | 2015 | 885 | 0.090 |
Why?
| | Cytoskeleton | 1 | 2013 | 192 | 0.090 |
Why?
| | Hormones | 2 | 2010 | 138 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 837 | 0.090 |
Why?
| | Histones | 1 | 2017 | 655 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2020 | 1116 | 0.090 |
Why?
| | Research Design | 1 | 2018 | 1113 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 36 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 170 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 310 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 2 | 2017 | 2388 | 0.090 |
Why?
| | Biomarkers | 6 | 2019 | 4207 | 0.090 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2103 | 0.090 |
Why?
| | Multienzyme Complexes | 2 | 2001 | 66 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 188 | 0.080 |
Why?
| | Glycolysis | 1 | 2012 | 331 | 0.080 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 392 | 0.080 |
Why?
| | Colon | 1 | 2013 | 304 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2018 | 6324 | 0.080 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 19 | 0.080 |
Why?
| | Patient Compliance | 1 | 2014 | 613 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4638 | 0.080 |
Why?
| | Metalloproteases | 1 | 2010 | 42 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 371 | 0.080 |
Why?
| | Genetic Variation | 1 | 2015 | 999 | 0.080 |
Why?
| | Acetaminophen | 1 | 2012 | 263 | 0.080 |
Why?
| | Perilipin-2 | 3 | 2015 | 41 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 314 | 0.080 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.080 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 261 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 574 | 0.080 |
Why?
| | Hypertension | 1 | 2018 | 1257 | 0.080 |
Why?
| | Fats | 1 | 2009 | 18 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 197 | 0.070 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 198 | 0.070 |
Why?
| | Adolescent | 6 | 2025 | 22326 | 0.070 |
Why?
| | Health Behavior | 1 | 2014 | 788 | 0.070 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 158 | 0.070 |
Why?
| | Young Adult | 6 | 2025 | 13878 | 0.070 |
Why?
| | Interleukin-4 | 1 | 2009 | 216 | 0.070 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 360 | 0.070 |
Why?
| | Self Report | 1 | 2013 | 871 | 0.070 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 1391 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2014 | 195 | 0.070 |
Why?
| | Disease Susceptibility | 3 | 2016 | 353 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2009 | 450 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 580 | 0.070 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2023 | 548 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 27 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 174 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1758 | 0.070 |
Why?
| | Antigens, CD34 | 1 | 2007 | 88 | 0.070 |
Why?
| | Risk Factors | 3 | 2018 | 10593 | 0.070 |
Why?
| | Animals, Genetically Modified | 2 | 2018 | 245 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2016 | 11298 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 185 | 0.060 |
Why?
| | Patient Selection | 2 | 2009 | 689 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 102 | 0.060 |
Why?
| | Nuclear Transfer Techniques | 2 | 2017 | 5 | 0.060 |
Why?
| | Leukocyte Count | 1 | 2007 | 317 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2878 | 0.060 |
Why?
| | Phylogeny | 2 | 2021 | 1003 | 0.060 |
Why?
| | Lactates | 3 | 1995 | 85 | 0.060 |
Why?
| | Exercise Test | 1 | 2009 | 623 | 0.060 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 186 | 0.060 |
Why?
| | Calorimetry | 3 | 2012 | 71 | 0.060 |
Why?
| | Multilocus Sequence Typing | 1 | 2025 | 17 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2022 | 780 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 61 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2006 | 80 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 807 | 0.060 |
Why?
| | Peptide YY | 1 | 2025 | 17 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 2008 | 0.060 |
Why?
| | Glucose Transporter Type 4 | 2 | 2002 | 39 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 7 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1642 | 0.060 |
Why?
| | Lipolysis | 1 | 2005 | 46 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2018 | 16626 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3604 | 0.060 |
Why?
| | Models, Biological | 2 | 2018 | 1821 | 0.060 |
Why?
| | Proteins | 2 | 2013 | 1013 | 0.060 |
Why?
| | Population Dynamics | 1 | 2025 | 155 | 0.060 |
Why?
| | Proteomics | 2 | 2022 | 1152 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2980 | 0.050 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 208 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 142 | 0.050 |
Why?
| | Macrophages | 1 | 2012 | 1496 | 0.050 |
Why?
| | Kinetics | 2 | 2012 | 1626 | 0.050 |
Why?
| | Antigens, CD | 1 | 2007 | 545 | 0.050 |
Why?
| | Myogenic Regulatory Factors | 2 | 2001 | 45 | 0.050 |
Why?
| | Organ Specificity | 1 | 2005 | 310 | 0.050 |
Why?
| | MEF2 Transcription Factors | 2 | 2001 | 50 | 0.050 |
Why?
| | Pilot Projects | 2 | 2022 | 1829 | 0.050 |
Why?
| | Manure | 1 | 2023 | 10 | 0.050 |
Why?
| | Colony Count, Microbial | 1 | 2023 | 124 | 0.050 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 5 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 629 | 0.050 |
Why?
| | Food Microbiology | 1 | 2023 | 73 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 263 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 388 | 0.050 |
Why?
| | Food Deprivation | 1 | 2003 | 27 | 0.050 |
Why?
| | Protein Kinases | 2 | 2002 | 309 | 0.050 |
Why?
| | Occult Blood | 1 | 2023 | 39 | 0.050 |
Why?
| | Hexokinase | 1 | 2022 | 17 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 268 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 21 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Aged | 5 | 2018 | 25117 | 0.050 |
Why?
| | Sex Factors | 2 | 2019 | 2074 | 0.050 |
Why?
| | Lactic Acid | 4 | 2002 | 306 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 111 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 53 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 76 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2081 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 89 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 117 | 0.050 |
Why?
| | Rodentia | 1 | 2022 | 59 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 82 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 40 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 85 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 134 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 181 | 0.050 |
Why?
| | Clostridium | 1 | 2021 | 19 | 0.040 |
Why?
| | Bacillus | 1 | 2021 | 17 | 0.040 |
Why?
| | Mice, Obese | 1 | 2021 | 66 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2001 | 12 | 0.040 |
Why?
| | Interleukin-13 | 1 | 2022 | 149 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2003 | 222 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 269 | 0.040 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 58 | 0.040 |
Why?
| | Neutrophils | 1 | 2007 | 1124 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 136 | 0.040 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 38 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 211 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 317 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 72 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 42 | 0.040 |
Why?
| | Intestines | 2 | 2015 | 355 | 0.040 |
Why?
| | Hemoglobins | 1 | 2023 | 363 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 76 | 0.040 |
Why?
| | Farms | 1 | 2020 | 7 | 0.040 |
Why?
| | Molecular Typing | 1 | 2020 | 21 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1866 | 0.040 |
Why?
| | Colonoscopy | 1 | 2023 | 251 | 0.040 |
Why?
| | Calmodulin | 1 | 2000 | 71 | 0.040 |
Why?
| | Hindlimb | 3 | 1995 | 135 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 747 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2021 | 345 | 0.040 |
Why?
| | Calcineurin | 1 | 2000 | 108 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 106 | 0.040 |
Why?
| | Lipoproteins, HDL | 1 | 2000 | 78 | 0.040 |
Why?
| | Plasmids | 1 | 2021 | 369 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2000 | 271 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 112 | 0.040 |
Why?
| | Medicago sativa | 1 | 2019 | 3 | 0.040 |
Why?
| | Rumen | 1 | 2019 | 7 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 17 | 0.040 |
Why?
| | Benzylamines | 1 | 2019 | 44 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2018 | 8020 | 0.040 |
Why?
| | Protein Kinase C | 1 | 2000 | 252 | 0.040 |
Why?
| | New Zealand | 1 | 2019 | 55 | 0.040 |
Why?
| | Ileostomy | 1 | 2019 | 26 | 0.040 |
Why?
| | Benzoates | 1 | 2019 | 49 | 0.040 |
Why?
| | Postprandial Period | 1 | 2019 | 116 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 213 | 0.040 |
Why?
| | Child | 2 | 2022 | 22562 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 36 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2019 | 135 | 0.040 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 117 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 7862 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 326 | 0.040 |
Why?
| | Colectomy | 1 | 2019 | 107 | 0.040 |
Why?
| | Japan | 1 | 2018 | 134 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5700 | 0.040 |
Why?
| | Huntingtin Protein | 1 | 2017 | 13 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 1977 | 0.030 |
Why?
| | Transfection | 1 | 2000 | 936 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 441 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 38 | 0.030 |
Why?
| | Stromal Cells | 1 | 2018 | 121 | 0.030 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2017 | 44 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2018 | 184 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 29 | 0.030 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 142 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 672 | 0.030 |
Why?
| | Muscle Contraction | 1 | 2000 | 430 | 0.030 |
Why?
| | Cytokines | 2 | 2018 | 2093 | 0.030 |
Why?
| | Blastocyst | 1 | 2017 | 48 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1225 | 0.030 |
Why?
| | Breast | 1 | 2018 | 156 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 27 | 0.030 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 44 | 0.030 |
Why?
| | Cyclic AMP | 2 | 1995 | 215 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 350 | 0.030 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 98 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 616 | 0.030 |
Why?
| | Neoplasms | 1 | 2012 | 2761 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 163 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 225 | 0.030 |
Why?
| | Isoenzymes | 2 | 2012 | 296 | 0.030 |
Why?
| | Brain | 2 | 2021 | 2875 | 0.030 |
Why?
| | Meat | 1 | 2018 | 93 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 600 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.030 |
Why?
| | Erythrocytes | 1 | 2022 | 701 | 0.030 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.030 |
Why?
| | Methylation | 1 | 2017 | 239 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2017 | 87 | 0.030 |
Why?
| | Epinephrine | 2 | 1994 | 148 | 0.030 |
Why?
| | Progesterone | 1 | 1998 | 258 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2018 | 281 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 197 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1185 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 367 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 157 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 165 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 222 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 192 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 121 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 612 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 857 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2017 | 186 | 0.030 |
Why?
| | Disease Resistance | 1 | 2015 | 28 | 0.030 |
Why?
| | Biological Products | 1 | 2019 | 243 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2015 | 18 | 0.030 |
Why?
| | Endonucleases | 1 | 2015 | 33 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2015 | 52 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 453 | 0.030 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 34 | 0.030 |
Why?
| | Gestational Age | 1 | 2019 | 961 | 0.030 |
Why?
| | Phosphocreatine | 1 | 1995 | 44 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1351 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2015 | 365 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 2007 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4167 | 0.030 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 77 | 0.030 |
Why?
| | Fructosediphosphates | 1 | 1994 | 1 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1179 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 853 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1081 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 332 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 738 | 0.030 |
Why?
| | Genetic Loci | 1 | 2015 | 277 | 0.030 |
Why?
| | Perfusion | 1 | 1995 | 240 | 0.030 |
Why?
| | Lipids | 1 | 1998 | 687 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Hot Temperature | 1 | 2016 | 406 | 0.030 |
Why?
| | Testosterone | 1 | 2017 | 418 | 0.030 |
Why?
| | Cell Respiration | 1 | 2013 | 107 | 0.030 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 31 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3362 | 0.020 |
Why?
| | Betaine | 1 | 2013 | 65 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 86 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 2019 | 588 | 0.020 |
Why?
| | Muscles | 1 | 1994 | 331 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 497 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 158 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2146 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 677 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 146 | 0.020 |
Why?
| | Intestine, Small | 1 | 2013 | 158 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 140 | 0.020 |
Why?
| | Base Sequence | 1 | 2015 | 2176 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1745 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2817 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 759 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2927 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2916 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 315 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1496 | 0.020 |
Why?
| | Metabolism | 1 | 2010 | 43 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 510 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1881 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5270 | 0.020 |
Why?
| | Glycerol | 1 | 2009 | 90 | 0.020 |
Why?
| | Liver Glycogen | 2 | 2002 | 16 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3546 | 0.020 |
Why?
| | Hypoglycemia | 1 | 1994 | 473 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3562 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 491 | 0.020 |
Why?
| | Phenotype | 2 | 2008 | 3184 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 401 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 634 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 224 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 974 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 29 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3776 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 21 | 0.020 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 14 | 0.020 |
Why?
| | Breeding | 1 | 2006 | 66 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 32 | 0.020 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 30 | 0.020 |
Why?
| | PPAR alpha | 1 | 2006 | 57 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 31 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 2006 | 93 | 0.010 |
Why?
| | Adenoviridae | 1 | 2006 | 200 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2006 | 241 | 0.010 |
Why?
| | Introns | 1 | 2005 | 253 | 0.010 |
Why?
| | Mutation | 1 | 2015 | 4024 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 2006 | 213 | 0.010 |
Why?
| | Enzymes | 1 | 2003 | 65 | 0.010 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 9 | 0.010 |
Why?
| | Oxazoles | 1 | 2002 | 46 | 0.010 |
Why?
| | Ketones | 1 | 2002 | 52 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 134 | 0.010 |
Why?
| | Ribonucleotides | 1 | 2001 | 26 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 130 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2867 | 0.010 |
Why?
| | Tyrosine | 1 | 2002 | 229 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 785 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1931 | 0.010 |
Why?
| | RNA | 1 | 2003 | 929 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 835 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 9 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 326 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 6 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 333 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 91 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3316 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1220 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 502 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|